Literature DB >> 8755745

Histidine-450 is the catalytic residue of L-3-hydroxyacyl coenzyme A dehydrogenase associated with the large alpha-subunit of the multienzyme complex of fatty acid oxidation from Escherichia coli.

X Y He1, S Y Yang.   

Abstract

Multienzyme complexes of fatty acid oxidation from Escherichia coli with Gln or Ala substituting for His450 or with Ala in place of Gly322 in the large alpha-subunit have been purified and characterized. The alpha/Gly322-->Ala mutation did not significantly affect the catalytic efficiencies (kcat/k(m)) of different component enzymes except for a 6.1-fold decrease in the kcat/k(m) of L-3-hydroxyacyl-CoA dehydrogenase and a 10-fold increase in the k(m) for NADH. This observation confirms the prediction [Yang, X.-Y. H., Schulz, H., Elzinga, M., & Yang, S.-Y. (1991) Biochemistry 30, 6788-6795] that the E. coli dehydrogenase has an NAD-binding site at its amino-terminal domain and structurally resembles the pig heart dehydrogenase. The pH dependence of the kcat/k(m) of the E. coli dehydrogenase suggested the catalytic involvement of an amino acid residue with a pKa of 6, which is presumably a histidine residue as proposed previously on the basis of chemical modifications. Since His450 of the E. coli multifunctional protein is the only histidine conserved in all known L-3-hydroxyacyl-CoA dehydrogenases, and since its counterpart in pig heart enzyme appeared to be close to the 3-keto group of the fatty acyl moiety of the substrate, His450 was replaced by either Gln or Ala. The catalytic properties of 3-ketoacyl-CoA thiolase, enoyl-CoA hydratase, and delta 3-cis-delta 2-trans-enoyl-CoA isomerase of the alpha/His450-->Gln mutant complex were virtually unchanged except for a small decrease in the kcat values of the latter two enzymes. In contrast, the dehydrogenase of this mutant complex was almost inactive due to a greater than 3000-fold decrease in its kcat and a 6-fold increase in the k(m) for NADH. The alpha/His450-->Ala mutant complex showed similar catalytic behaviors. Taken together, several lines of evidence lead to the conclusion that His450 is the catalytic residue of L-3-hydroxyacyl-CoA dehydrogenase of the E. coli multifunctional fatty acid oxidation protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755745     DOI: 10.1021/bi960374y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Pig heart short chain L-3-hydroxyacyl-CoA dehydrogenase revisited: sequence analysis and crystal structure determination.

Authors:  J J Barycki; L K O'Brien; J J Birktoft; A W Strauss; L J Banaszak
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

2.  YfcX enables medium-chain-length poly(3-hydroxyalkanoate) formation from fatty acids in recombinant Escherichia coli fadB strains.

Authors:  Kristi D Snell; Feng Feng; Luhua Zhong; David Martin; Lara L Madison
Journal:  J Bacteriol       Date:  2002-10       Impact factor: 3.490

3.  A nucleotide-dependent oligomerization of the Escherichia coli replication initiator DnaA requires residue His136 for remodeling of the chromosomal origin.

Authors:  Rahul Saxena; Christopher B Stanley; Pankaj Kumar; Matthew J Cuneo; Digvijay Patil; Jyoti Jha; Kevin L Weiss; Dhruba K Chattoraj; Elliott Crooke
Journal:  Nucleic Acids Res       Date:  2020-01-10       Impact factor: 16.971

4.  Metabolic engineering strategies to produce medium-chain oleochemicals via acyl-ACP:CoA transacylase activity.

Authors:  Qiang Yan; William T Cordell; Michael A Jindra; Dylan K Courtney; Madeline K Kuckuk; Xuanqi Chen; Brian F Pfleger
Journal:  Nat Commun       Date:  2022-03-25       Impact factor: 17.694

5.  Identification of palmitoylated mitochondrial proteins using a bio-orthogonal azido-palmitate analogue.

Authors:  Morris A Kostiuk; Maria M Corvi; Bernd O Keller; Greg Plummer; Jennifer A Prescher; Matthew J Hangauer; Carolyn R Bertozzi; Gurram Rajaiah; John R Falck; Luc G Berthiaume
Journal:  FASEB J       Date:  2007-10-30       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.